Press Releases

The Medicines Patent Pool welcomes press inquiries. Journalists looking to get in touch with the MPP can contact the communications team by emailing gro.looptnetapsenicidemnull@sserp

 

MPP Press Releases

2016

07 July 2016
The Medicines Patent Pool Signs New Round of Generic Manufacturing Licences for HIV and Hepatitis C Treatments

25 April 2016
ViiV Healthcare, Medicines Patent Pool Extend Licence for Dolutegravir to all Lower Middle-Income Countries

20 April 2016

TB Alliance and the Medicines Patent Pool Sign Memorandum of Understanding to Improve Access to TB Medicines in Resource-Limited Nations

21 March 2016
Executive Director Statement on the Appointment of New Chair of the Medicines Patent Pool Governance Board

20 January 2016
The Medicines Patent Pool Signs First Sub-licences for Hepatitis C Medicine Daclatasvir

2015

18 December 2015
The Medicines Patent Pool and AbbVie Sign Licensing Agreement to Increase Access to Crucial HIV Treatments Throughout Africa

1 December 2015
The Medicines Patent Pool Signs a Collaborative Agreement with the University of Liverpool to Develop HIV Nanomedicines

23 November 2015
The Medicines Patent Pool Signs Licence with Bristol-Myers Squibb to Increase Access to Hepatitis C Medicine Daclatasvir

06 November 2015
The Medicines Patent Pool Expands Mandate to Hepatitis C and Tuberculosis Treatment

27 October 2015
The Medicines Patent Pool Announces Expansion of its Governance Board

01 July 2015 
The Medicines Patent Pool Increases its Generic Manufacturing Network to Ramp-Up Production of Low Cost Antiretrovirals

11 June 2015
The Medicines Patent Pool and Gilead Sciences Expand Licence to Allow Generic Manufacture of Medicines in South Africa

09 June 2015
The Medicines Patent Pool Announces Two New Chinese Generic Partners

20 May 2015
The Medicines Patent Pool Releases 2014 Annual Report: Highlights Progress in Increasing Access to HIV Medicines

24 February 2015
The Medicines Patent Pool Signs Licensing Agreement with MSD for Paediatric Formulations of Raltegravir

 

2014

01 December 2014
The Medicines Patent Pool (MPP) Signs Licensing Agreement with AbbVie for HIV Paediatric Formulations of Lopinavir and Ritonavir

17 November 2014
Access to Medicine Index Applauds the Medicines Patent Pool for High Standard Licences

25 September 2014
The Medicines Patent Pool Adds New Sub-Licensing Agreements to Improve Access to Novel ARVs in Developing Countries

23 July 2014
The Medicines Patent Pool (MPP) Broadens Collaboration with Gilead Sciences: Signs Licence for Phase III Medicine Tenofovir Alafenamide (TAF)

17 July 2014
The Medicines Patent Pool Signs A Record Seven New Sub-Licences to Speed the Availability of Generic HIV Medicines to Developing Countries

19 May 2014
Paediatric HIV Treatment Initiative (PHTI) To Spur Innovation And Access To Improve The Lives Of Children Living With HIV

01 April 2014
Medicines Patent Pool, ViiV Healthcare Sign Licence for The Most Recent HIV Medicine To Have Received Regulatory Approval

 

2013

12 December 2013
MPP and Bristol-Myers Squibb Sign Agreement to Further Expand Access to a Key HIV Medicine

5 August 2013
Medicines Patent Pool and Roche Sign HIV Medicines Agreement: Focus on Preventing Blindness in People Living with HIV

27 February 2013
Medicines Patent Pool, ViiV Healthcare Collaborate to Treat Paediatric HIV

 

2012

25 July 2012
Hetero Joins the Patent Pool, Signing Licence to Produce Low-Cost HIV Medicines

2 February 2012
Key Generic Manufacturer Emcure Licenses from Medicines Patent Pool

 

2011

1 December 2011
Medicines Patent Pool: Tremendous Progress in First Year of Existence; Press statement on World AIDS Day

11 October 2011
Generic Companies Join the Patent Pool

18 July 2011
Medicines Patent Pool Announces Negotiations With Two Additional Pharmaceutical Companies

12 July 2011
Medicines Patent Pool Signs Licence Agreement with Gilead to Increase Access to HIV/AIDS Medicines

4 April 2011
Medicines Patent Pool Launches Patent Information Resource to Aid People Working To Increase Access to HIV Medicines

 

2010

30 September 2010
US National Institutes of Health (NIH) First to Share Patents with Medicines Patent Pool As it Opens for Business [pdf]

To get the latest information, sign up for the MPP’s newsletter, or email gro.looptnetapsenicidemnull@sserp to be added to our press list.

This page is also available in: French, Spanish